share_log

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

SEC announcement ·  Feb 29 16:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more